Financials

  • Market Capitalization 84.9401 M
  • Employee 13
  • Founded 2018
  • CEO N/A
  • Website www.maiabiotech.com
  • Headquarter Delaware, United States
  • FIGI BBG0113Q7J88
  • Industry Technology
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物

MAIA Biotechnology Inc

MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells.

新闻